RxDoctor Payments Data

Veronica Chiang, MD

Neurological Surgery · New Haven, CTNPI 1073594487

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $25,150 of the $40,288 with a category attached, or 62.4%. Monteris Medical Corporation accounts for 77.1% of it on its own, with 7 other manufacturers making up the rest.

$40,288in general payments, 2019–2025

Across 74 payments — averaging $544.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Monteris Medical Corporation$31K
  • Elekta Instrument AB$7K
  • Brainlab, Inc.$1K
  • Clearpoint Neuro, Inc.$290
  • Siemens Medical Solutions USA, Inc.$222
  • Medtronic$112
  • plus $153 from 2 others
$159,805in research payments, 2019–2025

Across 55 payments — averaging $2905.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Monteris Medical Corporation$160K

What the payments were for

  • Consulting fees$25,15062%
  • Speaking & faculty fees$1,0002%
  • Travel & lodging$11,68629%
  • Food & beverage$2,4526%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Monteris Medical Corporation59$31,062
Elekta Instrument AB5$7,449
Brainlab, Inc.1$1,000
Clearpoint Neuro, Inc.3$290
Siemens Medical Solutions USA, Inc.3$222
Medtronic1$112
Zap Surgical Systems, Inc.1$104
Varian Medical Systems, Inc.1$49

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$40,288 in reported general payments places this provider in the 75th percentile of 94 neurological surgery providers in Connecticut.

See all neurological surgery providers in Connecticut

Medicare billing

Part B allowed, 2024
$217,400
Medicare patients
95
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam36$640
Dexamethasone20$229

Paid to pharmacies, not to this prescriber.

Other neurological surgery in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →